本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.4604
+0.045811.05%
盘后0.46990.0095+2.06%19:51 EDT
成交量:393.98万
成交额:182.57万
市值:6,518.14万
市盈率:-0.61
高:0.4940
开:0.4193
低:0.3997
收:0.4146
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

SEC问询函

Form CORRESP - Correspondence
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/22

SEC问询函

Form CORRESP - Correspondence
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/14

重要事件披露

Form 8-K - Current report